India known as nation with world's largest healthcare programme: PM Modi

Prime Minister Narendra Modi said India has made healthcare more affordable and accessible over the past 12 years through initiatives such as Ayushman Bharat and the PM Bharatiya Jan Aushadhi Pariyojana. He highlighted lower-cost medicines and medical devices, expanded medical education, and progress in tackling diseases like tuberculosis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/b0K2LuN
via IFTTT

Read More

Maharashtra FDA bars hospitals from forcing patients to buy medicines in-house

Maharashtra's Food and Drug Administration has issued a significant directive. Hospitals and medical practitioners must now allow patients to purchase medicines from any licensed pharmacy. Patients will receive their prescriptions directly. This move aims to prevent unfair trade practices and protect patient consumer rights.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/htfYjdp
via IFTTT

Read More

Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriers

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While offering potential benefits, experts highlight concerns about its high cost and the need for early diagnosis. The drug's real-world impact in India remains a subject of discussion among neurologists and the company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Mp3YCOg
via IFTTT

Read More

India raises price cap on cancer drugs to tackle shortage

India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused by a sharp rise in platinum costs. The National Pharmaceutical Pricing Authority (NPPA) approved the one-time hike in public interest after supply disruptions affected hospitals across the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fkU3Y9y
via IFTTT

Read More

UK approves Novo weight-loss pill to edge open European market

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatment. Over 10 million people with obesity in the UK now have an alternative to injections. Drugmakers are racing to expand use of these transformative medicines. The market is expected to reach over 100 billion dollars by 2030.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Qb8KzFm
via IFTTT

Read More

Regulators tighten GMP oversight of pharma plants

Several states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is issued, people in the know told ET. The inspections will now be applicable to all manufacturing units without exception including MSMEs, which had previously been granted a relaxation period that lapsed in January.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nCWQ6U1
via IFTTT

Read More

India needs to remain attractive for innovation-led investment: Judith Love, Novartis

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The company underscores the importance of collaboration to tackle obstacles like high costs and inadequate infrastructure.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GP6dNjY
via IFTTT

Read More